How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

07/09/2023 26 min
How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

Listen "How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes"

Episode Synopsis

In this podcast episode, our guest is Mark McDonough, CEO of ChromaCode.

ChromaCode is an innovator in genomics with a multiplexing platform that is driving integration from laboratories to physicians to patients, connecting them to the right treatment through its proven HDPCR™ multiplexing platform. This adaptable technology expands the accessibility of diagnostic applications to patient communities with a cost effective and scalable dPCR-based solution compatible with existing instrumentation and using standard workflows

More episodes of the podcast Rx for Biotech